PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$16.99M
Total Shares
17.94M
Net Share Change
-237.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Patient Capital Management
$16.99M17.94M shares
TRIM-237.0K(-1.3%)